Immunic, Inc.
IMUX· Nasdaq
Released Nov 5, 2020, after the close
10-Q filed Nov 6, 2020, 37 days after period end · 0001280776-20-000035
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Net Income | -$12.91M | -$8.22M | -$1.80M | -$12.48M |
| EPS Diluted | -$0.70 | -$0.82 | -$2.12 | -$0.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR